Skip to Content

UK Edition. Click here for US version.


Active substance(s): CEFOTAXIME SODIUM

PDF options:  View Fullscreen   Download PDF

PDF Transcript

Cefotaxime 500 mg powder for solution for injection
Cefotaxime 1 g powder for solution for injection or infusion
Cefotaxime 2 g powder for solution for injection or infusion

Read all of this leaflet carefully before you start using this medicine because it contains
important information for you.
- Keep this leaflet. You may need to read it again.
- If you have any further questions, ask your doctor, pharmacist or nurse.
- If you get any side effects, talk to your doctor, pharmacist or nurse. This includes any possible side
effects not listed in this leaflet. See section 4.
What is in this leaflet:
What Cefotaxime Injection is and what it is used for
What you need to know before you use Cefotaxime Injection
How to use Cefotaxime Injection
Possible side effects
How to store Cefotaxime Injection
Contents of the pack and other information


Cefotaxime Injection is an antibiotic belonging to a group called “cephalosporins”. It is generally
effective to fight a range of micro-organism. It is used for the treatment of a range of serious bacterial
infections of:
• the lungs (pneumonia)
• the urinary tract
• the membranes covering the brain (meningitis)
• the abdomen
• the skin and soft tissue
• the genitals with gonococci
• preoperative prophylaxis in colorectal surgery


Do not use Cefotaxime Injection:
• if you are allergic (hypersensitive) to cefotaxime or any other cephalosporins
• if you previously had acute and/or severe allergic reactions to penicillin or any other beta-lactam
If given as an injection into the muscle:
Your doctor may consider it necessary to inject this medicine into a muscle. In this case, the doctor
will add lidocaine to the injection to make it less painful. However, this method of administering the
injection will not be suitable for everyone and should not be given:

to infants under 30 months

if you are allergic (hypersensitive) to lidocaine or other local anaesthetics of the amide type

if you have irregular heartbeat

if you have heart problems which can cause shortness of breath or ankle swelling
if you are receiving Cefotaxime Injection intravenously (directly into your bloodstream)

Please inform your doctor if one of these applies to you so that your doctor can decide on the form of
Warnings and precautions
Tell your doctor or healthcare professional if:
• you have ever had an allergic or hypersensitive reaction to penicillin or other medicines from the
penicillin family (beta-lactam-antibiotics)
• experience skin reactions. Contact your doctor immediately
• you suffer from severe allergies or asthma
• you develop severe persistent (bloody) diarrhoea. You may have an inflammation of the large
intestine caused by the use of cefotaxime. In that case, the use of Cefotaxime Injection must be
stopped immediately. Do not take medicines that reduce bowel movements
• you have kidney problems
• you are on a low-sodium (low salt) diet
If any of these apply to you, your doctor may want to change your treatment or give you special
Cefotaxime Injection may cause you to become infected with organisms that are unsusceptible to
antibiotics, so your doctor will monitor your condition. If you become infected, your doctor may start
a specific therapy.
This medicine can alter the results of some blood and urine tests. If you are having blood tests
(such as Coombs’ test) or urinary sugar tests (the Fehling’s type which test for reducing sugars) tell
your doctor you are taking this medicine as this medicine may cause false positive results.
Your doctor may decide to do tests on your blood if you are given Cefotaxime Injection for longer
than 7 days.
Other medicines and Cefotaxime Injection
Please tell your doctor or healthcare professional if you are taking or have recently taken any other
medicines, including medicines obtained without a prescription.
Concomitant intake of:
• other antibiotics (such as penicillins, aminoglycosides, tetracyclines, erythromycin and
• diuretics (e.g. furosemide)
• probenecid (for the treatment of gout and arthritis) may increase or decrease the effect of
Cefotaxime Injection. Inform your doctor if you are in treatment with these medicines
The efficacy of oral contraceptives may be decreased by concomitant use of cefotaxime. Therefore
during treatment with Cefotaxime Injection additional contraceptive methods should be used.
Pregnancy and breast-feeding
Ask your doctor or pharmacist for advice before taking any medicine.

If you are pregnant or are planning to become pregnant, your doctor has to determine if a treatment
with Cefotaxime Injection is suitable for you.
Cefotaxime Injection excretes in breast milk in low concentrations. Therefore it should not be used
during breast-feeding.
Driving and using machines
The effect of cefotaxime on the ability to drive and use machines has not been investigated. However,
this medicine may cause impairment of consciousness, abnormal movements and dizziness in some
patients. If this happens, do not drive or use machines.
Important information about some of the ingredients of Cefotaxime Injection
This medicinal product contains 48 mg sodium per gram. To be taken into consideration by patients
on a controlled sodium diet.



Cefotaxime Injection is normally given by a doctor or nurse. You should check with your doctor or
healthcare professional if you are not sure.
Cefotaxime Injection should always be administered intravenously (in a vein) or intra muscular (in a
muscle). The injection will always be administered by a doctor.
Dose, method of application and intervals between injections depend on the sensitivity of the microorganism, the severity of your infection and your condition.
How much Cefotaxime Injection will be given?
Adults and adolescents (12 to 16-18 years) will usually be given 1 g every 12 hours. In severe
infections, this may be increased up to 12 g per day, given in 3-4 doses. For infections caused by
sensitive Pseudomonas species, daily doses of greater than 6 g will usually be required.
Children: The dose will depend on the size of your body; the usual dose is 50-100 mg/kg/day in 2-4
divided doses. In very severe infections, doses of up to 200 mg/kg/day may be required.
Babies (0-27 days): The recommended dosage is 50 mg/ kg/day in 2-4 divided doses. In severe
infections, doses of up to 150-200 mg/kg/day may be required.
Use in patients with kidney problems
If the condition of the kidneys is very poor (creatinine clearance of ≤ 5 ml/min), your doctor will
reduce the dosage by half after you have received an initial normal dose.
If you think you have been given too much Cefotaxime Injection
This is not likely, as the injection is given to you by a doctor. If you feel bad after administration of
the injection, please contact your doctor immediately.
If your doctor stops giving you Cefotaxime Injection
The doctor will continue treatment with Cefotaxime Injection until the infection treated is relieved.

If you have any further questions on the use of this product, ask your doctor.



Like all medicines, Cefotaxime Injection can cause side effects, although not everybody gets them.
Very common side effects (affects more than 1 user in 10):
• transient pain at the injection site
Uncommon side effects (affects 1 to 10 users in 1,000):
• reduced amount of white blood cells or of blood platelets
• reactions called “Jarisch-Herxhemier” which includes fever, shivering, headache and joint pain
• convulsions
• diarrhoea
• changes in liver values
• rash, itching and special skin rash named urticaria
• impaired kidney function
• fever
• inflammation at the injection site and of your veins (thrombophlebitis)
Not known (frequency cannot be estimated from the available data):
• infections with unsusceptible organisms (“Superinfections”)
• decrease in the number of a type of white blood cells (neutropenia)
• serious condition in which white blood cells decrease in number or disappear altogether
• low levels of red blood cells (anaemia)
• anaphylactoid reactions (that may range from mild to severe, including a sudden, generalised
allergic reaction that may lead to a life-threatening “anaphylactic” shock [e.g. difficulty in breathing,
drop of blood pressure, fast pulse])
• severe allergic reactions as swelling of the face, throat, and lips (angiooedema)
• bronchial spasms
• headache and dizziness
• brain disorders (e.g. impairment of consciousness, abnormal movements)
• irregular heartbeat
• feeling sick, vomiting
• pain in the abdomen
• a serious bacterial infection of your gut known as pseudomembranous colitis (including severe,
persistent or bloody diarrhoea associated with abdominal pain or fever)
• hepatitis, sometimes with jaundice
• serious skin conditions such as Steven-Johnsons syndrome, erythema multiforme and toxic
epidermal necrolysis
• reversible inflammation of the kidneys
• reactions to lidocaine if Cefotaxime Injection is given as a injection into a muscle
Reporting of side effects
If you get any side effects, talk to your doctor, pharmacist or nurse. This includes any possible side
effects not listed in this leaflet. You can also report side effects directly via the Yellow Card Scheme
at: By reporting side effects you can help provide more information on
the safety of this medicine.



Your doctor or pharmacist is responsible for storing Cefotaxime Injection. They are also responsible
for disposing of any unused Cefotaxime Injection correctly.
Keep this medicine out of the sight and reach of children.
Do not use Cefotaxime Injection after the expiry date which is stated on the vial and carton after EXP.
The expiry date refers to the last day of that month.
Store the unopened vial below 25°C. Keep container in the outer carton.
Once the powder has been dissolved, the solution should be used immediately or stored at 2-8°C and
discarded after 24 hours.
Do not throw away any medicines via wastewater or household waste. Ask your pharmacist how to
throw away medicines you no longer use. These measures will help protect the environment.



What Cefotaxime Injection contains
The active substance in Cefotaxime Injection is cefotaxime as the sodium salt. The total sodium (salt)
content is approximately 24, 48 or 96 mg respectively.
1 vial Cefotaxime Injection, 0.5 g contains 0.524 g cefotaxime sodium, corresponding to 500 mg
1 vial Cefotaxime Injection, 1 g contains 1.048 g cefotaxime sodium, corresponding to 1 g
1 vial Cefotaxime Injection, 2 g contains 2.096 g cefotaxime sodium, corresponding to 2 g
There are no other ingredients.
What Cefotaxime Injection looks like and contents of the pack
Cefotaxime Injection is a white to slightly yellow powder in a colourless glass vial. It is supplied in
500 mg, 1 g or 2 g vials with 1, 5, 10, 25 or 50 vials in a carton.
Not all pack sizes may be marketed
PL 39655/0019 - Cefotaxime 500 mg powder for solution for injection
PL 39655/0020 - Cefotaxime 1 g powder for solution for injection or infusion
PL 39655/0021 - Cefotaxime 2 g powder for solution for injection or infusion
Marketing Authorisation Holder:
Stravencon Ltd.
Landmark House
17 Hanover Square
London W1S 1HU

IPG Pharma Ltd
Atrium Court
The Ring
RG12 1BW, UK
This leaflet was last revised in July 2015.

Cefotaxime 500 mg injection and 1 g, 2 g injection or infusion
From the calculated dose, determine the appropriate number of vials to be used. Add the
recommended volume of reconstitution solution and shake well until the contents of the vial have
dissolved completely.
Route of
Intravenous or

Reconstitution solution
Water for injections Ph. Eur.

Water for Injections Ph. Eur.
Sodium Chloride Injection
5% Dextrose Injection BP
Dextrose and Sodium
Chloride Injection BP
Sodium lactate Injection BP

Diluent required
500 mg 1 g
2 ml
4 ml

10 ml

Displacement volume
500 mg 1 g

0.45 ml

0.9 ml

40-100 ml for 1-2 g of

Prepared injections should be used immediately.
Prepared infusion to be administered over 20-60 minutes.
Cefotaxime is for single patient use only, discard any unused solution.
Cefotaxime and aminoglycosides should not be mixed in the same syringe or perfusion fluid.
Reconstitute with:
Water for Injections Ph. Eur.
Sodium Chloride Injection BP
5% Dextrose Injection BP
Dextrose and Sodium Chloride Injection BP
Sodium lactate Injection BP
Metronidazole Infusion (500 mg/100 ml)
1% lidocaine/lignocaine (freshly prepared)
The compatibility of cefotaxime in other infusion fluids should be checked before use.

1.8 ml

The reconstituted solution should be clear, do not use the solution if particles are present.

+ Expand Transcript

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.